ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access

Shadma Yaqoob1, Areena H. Siddiqui2 , R. Harsvardhan3, J. Ahmad4, V.K. Srivastava5, M.K. Verma6, P. Verma7 and A.N. Singh6

1Department of Microbiology, Era’s Medical College and Hospital, Lucknow – 226 003, India.
2Department of Lab Medicine, Sahara Hospital, Lucknow – 226 010, India.
3Department of Hospital Administration, Sanjay Gandhi Post Graduate Institute, Lucknow – 226 014, India.
4Department of Pharmacology, BRD Medical College, Gorakhpur – 273013, India.
5Lab Director, Cadmus Clinical Laboratories, Lucknow – 226 013, India.
6Department of Biochemistry, G.S.V.M. Medical College, Kanpur – 208 002, India.
7Department of Biotechnology, IFTM University, Moradabad – 244 001, India.
J Pure Appl Microbiol. 2020;14(suppl 1):775-788 | Article Number: 6339
Received: 07/05/2020 | Accepted: 17/05/2020 | Published: 23/05/2020
Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is alpha, beta, delta and theta have been identified till date and are responsible for human disease; causing influenza like illness (ILI). This virus has similar lineage of Middle East Respiratory Syndrome coronavirus (MERS-CoV) and related Coronavirus (SARS-CoV). This outbreak initially presented as pneumonia-like illness in a group of people in Wuhan, China. The infection was said to be caused by seafood and unusual animals in the wholesale markets of this city. SARS-CoV-2 is highly infectious and has resulted in a rapid pandemic. As of now it has spread to 197 countries with total no of cases in the world being 3.76 million as of early march. The mortality till now is 7.11% .The cases have been increasing since its first discovery in China. In India also the number has been increased. Till now India has total of 39,980 cases and mortality is attributed to be 3.26%. As per data from Ministry of health and family welfare (MoHFW) death is more commonly seen in males with age >60years. Among these most of the deaths were related to other co-morbid conditions. This article will help the readers with an overview of novel Coronavirus spanning around the clinical features, diagnostic modalities, treatment strategies and infection control measures. It will also help in raising awareness among healthcare workers regarding COVID-19 and aid in early recognition of these patients. Moreover, this review will also focus on the most recent information for the effective management, prevention, and treatment of patients worldwide.

Keywords

COVID-19, Pandemic, Immunoinformatics, MERS CoV, Resilience, SARS CoV-2

Article Metrics

Article View: 424

Share This Article

© The Author(s) 2020. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.